Modified peptides and their use for treating autoimmune diseases
US9657072B2 · kind B2 · utility
0Cited by
2References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 5, 2014 |
| Grant date | May 23, 2017 |
| Priority date | — |
| Expiry date | Mar 4, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a peptide, or a salt thereof, comprising or consisting of the amino acid sequence IHMVYSKRSGKPRGYAFIEY, comprising one or more post-translational modifications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.